In Highlight
The Year in Cardiology 2027: Where Today’s Science Meets Tomorrow’s Care
Join leading experts for two days of cutting-edge science, clinical insights and global collaboration.
Discover event
Research
We fund and support scientific research to advance treatments and improve outcomes.
Education
We empower healthcare professionals with knowledge, training and best practices.
Global Impact
We work worldwide to ensure equitable access to quality heart failure care.
Better Lives
Our mission is simple: to save lives and improve heart health.
News
View all news →
Virtual Visits in Heart Failure: Mapping Use Before Judging Impact3 September 2025
Neighbourhood Deprivation and Heart Failure Outcomes: A Cohort Study24 June 2025Featured Videos
View all →
Latest Literature
View all →▤Predicting Incident Heart Failure: How Well Do Risk Models Validate?Research · 25 April 2026▤Biomarker-Guided Heart Failure Management: Why Certainty of Evidence MattersEvidence-Based Medicine · 17 April 2026▤HFpEF Pharmacotherapy: What a Network Meta-analysis ComparedCardiovascular Pharmacotherapy · 15 February 2026▤Dapagliflozin Started During Heart Failure Hospitalisation: DAPA ACT HF-TIMI 68Cardiovascular Pharmacotherapy · 4 December 2025
Upcoming Events
View all events →Latest Articles from PubMed
- PAK4 as a cardiometabolic node: tissue-specific metabolic control, cardiovascular remodeling, and therapeutic trade-offs
- Associations of Plasma Branched-Chain Amino Acids With Incident Atherosclerotic Cardiovascular Disease by Sex and Type 2 Diabetes Status Among Chinese Adults
- Ceramides, Particularly Those Containing Very-Long-Chain Saturated Fatty Acids, Are Independently Associated With the Triglyceride-Glucose Index in European Individuals With Type 2 Diabetes
- Cumulative remnant cholesterol-adiposity product indices and incident cardiometabolic multimorbidity: a prospective CHARLS analysis
- Computed tomography diagnosis of post-myocardial infarction ventricular septal rupture with echocardiographic confirmation
- Bidirectional associations and shared plasma proteomic signatures of CKD and MASLD: evidence from a population-based prospective cohort and a real-world hospital cohort
